Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The numbers are small, but a few recent studies show a possible connection
No FDA-approved human trial
A new triple hormone weight loss injection in development Retatrutide is a once-weekly weight loss injection that targets three hormones: GLP-1, GIP, and glucagon
6 Athira Pharma LIFT-AD topline results (press release)September 3, 2024 announcement that fosgonimeton (a distinct HGF/c-Met modulator) did not meet the primary or key secondary endpoints in the Phase 2/3 LIFT-AD Alzheimers trial
Pratter issued Case Management Order No
She was on the medication for 16 weeks before she began to taper, cutting down over a period of six weeks
US$ 27.21
US$ 29.23
US$ 22.33
US$ 29.54
